Tirzepatide for obesity treatment and diabetes prevention
study055
10.1056/NEJMoa2409773
New England Journal of Medicine
randomized clinical trial
Long-term SURMOUNT-1 data evaluated tirzepatide for obesity with prediabetes.
Tirzepatide reduced weight and delayed progression to type 2 diabetes over three years.
tirzepatide
fat-loss|metabolism
advanced-metabolic-stack
semaglutide-vs-tirzepatide
published